Acute opioid use may cause choroidal thinning and retinal nerve fiber layer increase

References

• Ozsoy F, Alim S. Optical coherence tomography findings in patients with alcohol use disorder and their relationship with clinical parameters. Cutan Ocul Toxicol 2020; 39(1):54–60. doi:10.1080/15569527.2019.1700379.
   PubMed Web of Science ®Google Scholar
• Orum MH, Kalenderoglu A. Decreases in retinal nerve fiber layer thickness correlates with cumulative alcohol intake. J Addict Dis 2020; 38(4):400–10. doi:10.1080/10550887.2020.1776083.
   PubMed Web of Science ®Google Scholar
• Álvarez-Sesmero S, Povedano-Montero FJ, Arias-Horcajadas F, Marín-Mayor M, Navarrete-Chamorro P, Raga-Martínez I, Rubio G, López-Muñoz F. Retinal nerve fiber layer in patients with alcohol use disorder. Appl Sci 2019; 9(24):5331. doi:10.3390/app9245331.
   Google Scholar
• Ahuja S, Kumar PS, Kumar VP, Kattimani S, Akkilagunta S. Effect of chronic alcohol and tobacco use on retinal nerve fibre layer thickness: a case-control study. BMJ Open Ophthalmol 2017; 1(1):e000003. doi:10.1136/bmjophth-2016-000003.
   PubMed Web of Science ®Google Scholar
• Das D. The effect of chronic alcohol use on retinal nerve fiber layer thickness. Int J Sci 2019; 8(12):1–3. doi:10.36106/ijsr.
   Google Scholar
• Dayi A, Dayi O, Kurt E, Yorguner N. Optical coherence tomography findings in cannabis users. Turk Psikiyatri Derg 2020; 31(4):239–43. doi:10.5080/u25205.
   Google Scholar
• Kalenderoglu A, Orum MH, Karadag AS, Kustepe A, Celik M, Egilmez OB, Eken-Gedik D. Increases in retinal nerve fiber layer thickness may represent the neuroprotective effect of cannabis: an optical coherence tomography study. J Addict Dis 2020; 38(3):280–90. doi:10.1080/10550887.2020.1754109.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th edn. Arlington, VA: APP.
   Google Scholar
• Ögel K, Evren C, Karadağ F, Tamar-Gürol D. Bağımlılık Profil İndeksi’nin (BAPİ) geliştirilmesi, geçerlik ve güvenilirliği. Türk Psikiyatri Derg 2012; 23(4):264–73.
   Web of Science ®Google Scholar
• Ögel K, Koç C, Başabak A, İşmen EM, Görücü S. Bağımlılık Profil İndeksi Klinik Formunun (BAPİ-K) geliştirilmesi: Geçerlik ve güvenilirlik çalışması. Bağımlılık Dergisi 2015; 16(2):57–69.
   Google Scholar
• Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33 (6): 766–71.
   Google Scholar
• Kılıç M. Belirti Tarama Listesi (SCL-90-R)’nin geçerlilik ve güvenirliği. Psikolojik Danışma ve Rehberlik Dergisi 1991; 1(2):45–52.
   Google Scholar
• Doğan S, Öncü B, Ve Ark V-SG. Erişkin Dikkat Eksikliği Hiperaktivite Bozukluğu Kendi Bildirim Ölçeği (ASRS-v1.1): Türkçe formunun geçerlilik ve güvenilirliği. Anadolu Psikiyatri Derg 2009; 10:77–87.
   Web of Science ®Google Scholar
• Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci 2018; 41:453–73. doi:10.1146/annurev-neuro-080317-061522.
   PubMed Web of Science ®Google Scholar
• Sneader W. The discovery of heroin. Lancet 1998; 352(9141):1697–9. doi:10.1016/S0140-6736(98)07115-3.
   PubMed Web of Science ®Google Scholar
• Goldstein A. Heroin addiction: neurobiology, pharmacology, and policy. J Psychoactive Drugs 1991; 23(2):123–33. doi:10.1080/02791072.1991.10472231.
   PubMed Web of Science ®Google Scholar
• Narita M, Funada M, Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001; 89(1):1–15. doi:10.1016/s0163-7258(00)00099-1.
   PubMed Web of Science ®Google Scholar
• Stein C. Opioid receptors. Annu Rev Med 2016; 67:433–51. doi:10.1146/annurev-med-062613-093100.
   PubMed Web of Science ®Google Scholar
• Mercadante S, Porzio G, Gebbia V. New opioids. J Clin Oncol 2014; 32(16):1671–6. doi:10.1200/JCO.2013.51.8662.
   PubMed Web of Science ®Google Scholar
• Thigpen JC, Odle BL, Harirforoosh S. Opioids: a review of pharmacokinetics and pharmacodynamics in neonates, infants, and children. Eur J Drug Metab Pharmacokinet 2019; 44(5):591–609. doi:10.1007/s13318-019-00552-0.
   PubMed Web of Science ®Google Scholar
• Chaves C, Remiao F, Cisternino S, Decleves X. Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain. Curr Neuropharmacol 2017; 15(8):1156–73. doi:10.2174/1570159X15666170504095823.
   PubMed Web of Science ®Google Scholar
• George SR, Zastawny RL, Briones-Urbina R, Cheng R, Nguyen T, Heiber M, Kouvelas A, Chan AS, O'Dowd BF. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 1994; 205(2):1438–44. doi:10.1006/bbrc.1994.2826.
   PubMed Web of Science ®Google Scholar
• Peng J, Sarkar S, Chang SL. Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 2012; 124(3):223–8. doi:10.1016/j.drugalcdep.2012.01.013.
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) 2006; 184(2):139–44. doi:10.1007/s00213-005-0198-x.
   PubMed Web of Science ®Google Scholar
• Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 2010; 133(Pt 7):2098–114. doi:10.1093/brain/awq138.
   PubMed Web of Science ®Google Scholar
• Wollman SC, Alhassoon OM, Stern MJ, Hall MG, Rompogren J, Kimmel CL, Perez-Figueroa AM. White matter abnormalities in long-term heroin users: a preliminary neuroimaging meta-analysis. Am J Drug Alcohol Abuse 2015; 41(2):133–8. doi:10.3109/00952990.2014.985829.
   PubMed Web of Science ®Google Scholar
• Wollman SC, Alhassoon OM, Hall MG, Stern MJ, Connors EJ, Kimmel CL, Allen KE, Stephan RA, Radua J. Gray matter abnormalities in opioid-dependent patients: a neuroimaging meta-analysis. Am J Drug Alcohol Abuse 2017; 43(5):505–17. doi:10.1080/00952990.2016.1245312.
   PubMed Web of Science ®Google Scholar
• Moreno-Rius J. Opioid addiction and the cerebellum. Neurosci Biobehav Rev 2019; 107:238–51. doi:10.1016/j.neubiorev.2019.09.015.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Loh HH, Law PY. Effect of opioid on adult hippocampal neurogenesis. Sci World J 2016; 2016:2601264. doi:10.1155/2016/2601264.
   Google Scholar
• Büttner A, Mall G, Penning R, Weis S. The neuropathology of heroin use. Forensic Sci Int 2000; 113(1–3):435–42. doi:10.1016/S0379-0738(00)00204-8.
   PubMed Web of Science ®Google Scholar
• Jeong S, Kim SJ, Jeong C, Lee S, Jeong H, Lee J, Yoo KY. Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats. J Neurosurg Anesthesiol 2012; 24(1):51–7. doi:10.1097/ANA.0b013e3182368d70.
   PubMed Web of Science ®Google Scholar
• Lv MR, Li B, Wang MG, Meng FG, Yu JJ, Guo F, Li Y. Activation of the PI3K-Akt pathway promotes neuroprotection of the δ-opioid receptor agonist against cerebral ischemia-reperfusion injury in rat models. Biomed Pharmacother 2017; 93:230–7. doi:10.1016/j.biopha.2017.05.121.
   PubMed Web of Science ®Google Scholar
• Vaidya B, Sifat AE, Karamyan VT, Abbruscato TJ. The neuroprotective role of the brain opioid system in stroke injury. Drug Discov Today 2018; 23(7):1385–95. doi:10.1016/j.drudis.2018.02.011.
   PubMed Web of Science ®Google Scholar
• Silvia RC, Slizgi GR, Ludens JH, Tang AH. Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist. Brain Res 1987; 403(1):52–7. doi:10.1016/0006-8993(87)90121-1.
   PubMed Web of Science ®Google Scholar
• Husain S, Potter DE, Crosson CE. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci 2009; 50(8):3853–9. doi:10.1167/iovs.08-2907.
   PubMed Web of Science ®Google Scholar
• Örüm MH. Recent studies on optical coherence tomography findings in psychiatric disorders: 2018 data. Kafkas J Med Sci 2020; 10(2):171–2. doi:10.5505/kjms.2020.42204.
   Google Scholar
• Özen M, Kalenderoğlu A, Karadağ A, Örüm M. Comparison of optic coherence tomography results in patients diagnosed with OCD: findings in favor of neurodegeneration. Anadolu Psikiyatri Derg 2018; 20(0):1–74. doi:10.5455/apd.301482.
   Google Scholar
• Karadag AS, Kalenderoglu A, Orum MH. Optical coherence tomography findings in conversion disorder: are there any differences in the etiopathogenesis of subtypes? Arch Clin Psychiatry (São Paulo) 2018; 45(6):154–60. doi:10.1590/0101-60830000000179.
   Google Scholar